9.80
前日終値:
$10.29
開ける:
$9.97
24時間の取引高:
7,664
Relative Volume:
0.34
時価総額:
$860.14M
収益:
$213.45M
当期純損益:
$-72.46M
株価収益率:
-9.8631
EPS:
-0.9936
ネットキャッシュフロー:
$-47.28M
1週間 パフォーマンス:
-2.68%
1か月 パフォーマンス:
+17.22%
6か月 パフォーマンス:
+33.97%
1年 パフォーマンス:
+106.75%
Valneva Se Adr Stock (VALN) Company Profile
VALN を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
VALN
Valneva Se Adr
|
9.92 | 892.66M | 213.45M | -72.46M | -47.28M | -0.9936 |
|
VRTX
Vertex Pharmaceuticals Inc
|
463.95 | 118.58B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
749.78 | 79.40B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
811.57 | 51.18B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
360.78 | 48.88B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
339.19 | 37.49B | 4.98B | 69.59M | 525.67M | 0.5197 |
Valneva Se Adr Stock (VALN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-08-19 | 再開されました | H.C. Wainwright | Buy |
| 2022-08-03 | 開始されました | H.C. Wainwright | Buy |
Valneva Se Adr (VALN) 最新ニュース
Valneva stock falls after withdrawing chikungunya vaccine BLA in U.S. By Investing.com - Investing.com Nigeria
Valneva (NASDAQ:VALN) Sees Unusually-High Trading VolumeStill a Buy? - MarketBeat
Valneva (NASDAQ:VALN) Shares Gap UpWhat's Next? - MarketBeat
VLA Stock Price and Chart — EURONEXT:VLA - TradingView — Track All Markets
Valneva (NASDAQ:VALN) Shares Up 4.9%What's Next? - MarketBeat
Valneva (NASDAQ:VALN) Stock Price Down 4.6%Time to Sell? - MarketBeat
Valneva (NASDAQ:VALN) Sees Strong Trading VolumeHere's What Happened - MarketBeat
Frazier Life Sciences Management L.P. Makes New Investment in Valneva SE Sponsored ADR $VALN - MarketBeat
Valneva stock rises after positive final Phase 2 results for chikungunya vaccine - Investing.com India
VALNEVA Declaration of shares and voting rights: November 30, 2025 - GlobeNewswire Inc.
Valneva (NASDAQ:VALN) Stock Price Down 3.1%What's Next? - MarketBeat
Valneva stock rises after positive Lyme disease vaccine booster data - Investing.com
Valneva SE earnings beat by $0.02, revenue fell short of estimates - Investing.com
Valneva (VALN) Projected to Post Earnings on Thursday - MarketBeat
Disney, Brookfield, Nu Holdings and more set to report earnings Thursday - Investing.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SEVALN - 2822news.com
Free cash flow per share of Valneva SE Sponsored ADR – LS:A3CPD1 - TradingView
Valneva SE Sponsored ADR (NASDAQ:VALN) Short Interest Update - MarketBeat
Valneva's (VALN) Sell (D-) Rating Reiterated at Weiss Ratings - MarketBeat
Valneva (NASDAQ:VALN) Trading Down 0.8%Time to Sell? - MarketBeat
Valneva (NASDAQ:VALN) Trading Down 0.8% – Time to Sell? - Defense World
Valneva (NASDAQ:VALN) Stock Price Down 4.9%Here's Why - MarketBeat
Kepler Capital Sticks to Its Buy Rating for Valneva (0OB3) - Barchart.com
Valneva–Aktie: Finanzierung gesichert, Erwartungen gesenkt! - Finanztrends
Valneva (NASDAQ:VALN) Shares Gap DownWhat's Next? - MarketBeat
Valneva stock falls after FDA suspension forces guidance cut - Investing.com
Valneva’s Ixchiq shows 95% 4-year antibody persistence, shares up 10% - Investing.com
VALNEVA ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Valneva SE (VALN) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Valneva SE (VALN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Valneva Se Adr (VALN) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):